LCTX — LINEAGE CELL THERAPEUTICS INC COM

Ownership history in EverSource Wealth Advisors, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which EverSource Wealth Advisors, LLC reported a position in LINEAGE CELL THERAPEUTICS INC COM (LCTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 288 -714 -71.3% 0.00% $487 $1.69
2025 Q2 ADDED 1,002 +891 +802.7% 0.00% $909 $0.91
2025 Q1 INITIATED 111 — — 0.00% $50 $0.45
% of Fund (quarterly)    LCTX price (monthly, adj. close)

Other funds also holding LCTX

As of 2025 Q4 — sorted by position size

RAFFLES ASSOCIATES LP 3Y 7Y 6.72% BROADWOOD CAPITAL INC 3Y 7Y 4.86% Defender Capital, LLC. 3Y 3.7% Informed Momentum Co LLC 3Y 7Y 0.08% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.05% Catalyst Funds Management Pty Ltd 0.02% Beirne Wealth Consulting Services, LLC 3Y 7Y 0.02% ELCO Management Co., LLC 3Y 7Y 0.02% STONERIDGE INVESTMENT PARTNERS LLC 3Y 7Y 0.01% Piscataqua Savings Bank 3Y 0.01%
← Back to EverSource Wealth Advisors, LLC Holdings